 Paul Vrana
Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peromyscus | 21 | 2019 | 28 | 4.010 |
Why?
| | Genomic Imprinting | 8 | 2011 | 32 | 1.220 |
Why?
| | Insemination, Artificial | 3 | 2018 | 12 | 0.950 |
Why?
| | Models, Animal | 3 | 2014 | 350 | 0.840 |
Why?
| | Crosses, Genetic | 9 | 2014 | 141 | 0.780 |
Why?
| | Chimera | 3 | 2010 | 59 | 0.750 |
Why?
| | Placenta | 6 | 2010 | 624 | 0.730 |
Why?
| | Hybridization, Genetic | 6 | 2014 | 77 | 0.700 |
Why?
| | Genetic Variation | 4 | 2014 | 880 | 0.650 |
Why?
| | Behavior, Animal | 3 | 2019 | 472 | 0.590 |
Why?
| | Developmental Biology | 2 | 2007 | 18 | 0.580 |
Why?
| | Cell Separation | 2 | 2007 | 293 | 0.530 |
Why?
| | DNA Methylation | 5 | 2019 | 499 | 0.520 |
Why?
| | Embryonic Development | 2 | 2013 | 115 | 0.450 |
Why?
| | Neural Tube Defects | 1 | 2014 | 62 | 0.450 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2010 | 794 | 0.420 |
Why?
| | Animals | 29 | 2019 | 32104 | 0.400 |
Why?
| | Diet | 2 | 2019 | 1073 | 0.390 |
Why?
| | Dietary Supplements | 1 | 2015 | 458 | 0.380 |
Why?
| | Multigene Family | 3 | 2008 | 193 | 0.380 |
Why?
| | Embryo, Mammalian | 3 | 2011 | 214 | 0.370 |
Why?
| | Placentation | 1 | 2010 | 40 | 0.360 |
Why?
| | Oocytes | 3 | 2011 | 171 | 0.310 |
Why?
| | Phylogeny | 5 | 2014 | 805 | 0.310 |
Why?
| | Blastocyst | 2 | 2011 | 43 | 0.310 |
Why?
| | Organ Specificity | 1 | 2008 | 273 | 0.300 |
Why?
| | Oviducts | 1 | 2007 | 15 | 0.290 |
Why?
| | Species Specificity | 6 | 2011 | 552 | 0.290 |
Why?
| | Genes, cdc | 1 | 2007 | 10 | 0.280 |
Why?
| | Mice | 13 | 2018 | 15052 | 0.280 |
Why?
| | Spermatozoa | 1 | 2007 | 84 | 0.280 |
Why?
| | Stress, Physiological | 1 | 2008 | 399 | 0.250 |
Why?
| | Polymerase Chain Reaction | 3 | 2014 | 1001 | 0.250 |
Why?
| | Adaptation, Physiological | 1 | 2008 | 476 | 0.250 |
Why?
| | Alleles | 3 | 2011 | 794 | 0.240 |
Why?
| | Chromosome Mapping | 3 | 2014 | 489 | 0.240 |
Why?
| | Glucose | 1 | 2008 | 904 | 0.220 |
Why?
| | Extracellular Matrix | 1 | 2007 | 439 | 0.220 |
Why?
| | Pregnancy | 8 | 2011 | 5552 | 0.200 |
Why?
| | Evolution, Molecular | 3 | 2008 | 440 | 0.200 |
Why?
| | Placental Lactogen | 1 | 2001 | 20 | 0.200 |
Why?
| | Female | 18 | 2019 | 60016 | 0.190 |
Why?
| | Gonadal Dysgenesis | 1 | 2000 | 8 | 0.180 |
Why?
| | Male | 15 | 2019 | 56048 | 0.180 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 92 | 0.180 |
Why?
| | Genotype | 4 | 2014 | 1787 | 0.160 |
Why?
| | Folic Acid | 2 | 2019 | 159 | 0.150 |
Why?
| | Transcription Factors | 3 | 2011 | 1528 | 0.150 |
Why?
| | Base Sequence | 5 | 2011 | 2114 | 0.150 |
Why?
| | Ubiquitins | 1 | 1996 | 34 | 0.140 |
Why?
| | Biopolymers | 1 | 1996 | 26 | 0.140 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2353 | 0.140 |
Why?
| | Vertebrates | 1 | 1996 | 56 | 0.130 |
Why?
| | Social Behavior | 2 | 2019 | 269 | 0.130 |
Why?
| | DNA Primers | 3 | 2014 | 514 | 0.130 |
Why?
| | Molecular Sequence Data | 5 | 2011 | 2790 | 0.130 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2008 | 2098 | 0.120 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2015 | 34 | 0.120 |
Why?
| | Mammals | 1 | 1996 | 251 | 0.120 |
Why?
| | Hair Color | 1 | 2014 | 10 | 0.120 |
Why?
| | Blood Cells | 1 | 2014 | 38 | 0.120 |
Why?
| | Phenotype | 4 | 2014 | 2839 | 0.120 |
Why?
| | Disease | 1 | 2015 | 87 | 0.120 |
Why?
| | Animals, Laboratory | 1 | 2014 | 13 | 0.120 |
Why?
| | Carnivora | 1 | 1994 | 6 | 0.120 |
Why?
| | Animal Welfare | 1 | 2014 | 14 | 0.120 |
Why?
| | Cytochrome b Group | 1 | 1994 | 16 | 0.120 |
Why?
| | Ursidae | 1 | 1994 | 7 | 0.120 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2007 | 23 | 0.110 |
Why?
| | Animal Husbandry | 1 | 2014 | 33 | 0.110 |
Why?
| | Pigmentation | 1 | 2013 | 55 | 0.110 |
Why?
| | Sex Characteristics | 2 | 2014 | 641 | 0.100 |
Why?
| | Reproduction | 1 | 2013 | 180 | 0.100 |
Why?
| | Aggression | 1 | 2014 | 185 | 0.100 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2011 | 32 | 0.100 |
Why?
| | Epigenesis, Genetic | 1 | 2015 | 526 | 0.090 |
Why?
| | RNA, Messenger | 2 | 2010 | 2574 | 0.090 |
Why?
| | Fetal Death | 1 | 2010 | 49 | 0.090 |
Why?
| | Laminin | 1 | 2010 | 69 | 0.090 |
Why?
| | Pregnancy Proteins | 1 | 2010 | 36 | 0.090 |
Why?
| | Fetal Weight | 1 | 2010 | 52 | 0.090 |
Why?
| | Body Weight | 1 | 2014 | 867 | 0.090 |
Why?
| | Genetic Loci | 1 | 2011 | 264 | 0.090 |
Why?
| | Organ Size | 1 | 2010 | 434 | 0.080 |
Why?
| | DNA Replication | 1 | 2010 | 203 | 0.080 |
Why?
| | Ubiquitin-Specific Proteases | 1 | 2008 | 4 | 0.080 |
Why?
| | Y Chromosome | 1 | 2008 | 6 | 0.080 |
Why?
| | RNA, Messenger, Stored | 1 | 2008 | 12 | 0.080 |
Why?
| | Endopeptidases | 1 | 2008 | 72 | 0.080 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2008 | 61 | 0.080 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 930 | 0.080 |
Why?
| | Dioxygenases | 1 | 2008 | 25 | 0.080 |
Why?
| | Tissue Distribution | 1 | 2008 | 324 | 0.080 |
Why?
| | Sex Factors | 2 | 2005 | 1739 | 0.070 |
Why?
| | GRB10 Adaptor Protein | 1 | 2007 | 1 | 0.070 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2007 | 5 | 0.070 |
Why?
| | RNA, Untranslated | 1 | 2008 | 113 | 0.070 |
Why?
| | Rats | 3 | 2014 | 5033 | 0.070 |
Why?
| | X Chromosome | 1 | 2007 | 47 | 0.070 |
Why?
| | Zinc Fingers | 1 | 2007 | 44 | 0.070 |
Why?
| | Histocytochemistry | 1 | 2007 | 78 | 0.070 |
Why?
| | Genes, Homeobox | 1 | 2007 | 50 | 0.070 |
Why?
| | Proto-Oncogene Proteins | 1 | 2010 | 609 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2010 | 465 | 0.070 |
Why?
| | Collagen Type I | 1 | 2007 | 110 | 0.070 |
Why?
| | RNA, Long Noncoding | 1 | 2008 | 157 | 0.070 |
Why?
| | Trophoblasts | 1 | 2008 | 162 | 0.070 |
Why?
| | DNA Modification Methylases | 1 | 2005 | 14 | 0.070 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2006 | 65 | 0.070 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2007 | 139 | 0.060 |
Why?
| | Amino Acid Sequence | 2 | 2001 | 2000 | 0.060 |
Why?
| | Body Size | 1 | 2005 | 92 | 0.060 |
Why?
| | Homeostasis | 1 | 2008 | 577 | 0.060 |
Why?
| | MicroRNAs | 1 | 2011 | 607 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 746 | 0.060 |
Why?
| | Gene Frequency | 1 | 2005 | 485 | 0.060 |
Why?
| | Gene Deletion | 1 | 2006 | 355 | 0.060 |
Why?
| | Fetal Development | 1 | 2007 | 247 | 0.060 |
Why?
| | Cell Cycle | 1 | 2007 | 546 | 0.060 |
Why?
| | Genome | 1 | 2005 | 271 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2010 | 2194 | 0.050 |
Why?
| | Skin | 1 | 2007 | 662 | 0.050 |
Why?
| | Sequence Homology | 1 | 2001 | 40 | 0.050 |
Why?
| | Models, Biological | 1 | 2008 | 1646 | 0.050 |
Why?
| | Apoptosis | 1 | 2010 | 2377 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2008 | 1700 | 0.050 |
Why?
| | RNA | 1 | 2007 | 820 | 0.050 |
Why?
| | Fetal Viability | 1 | 2000 | 3 | 0.040 |
Why?
| | Gametogenesis | 1 | 2000 | 3 | 0.040 |
Why?
| | Genetic Markers | 2 | 2014 | 325 | 0.040 |
Why?
| | Opossums | 1 | 2000 | 10 | 0.040 |
Why?
| | Chickens | 1 | 2000 | 183 | 0.040 |
Why?
| | Betaine | 1 | 2019 | 63 | 0.040 |
Why?
| | Insulin | 1 | 2008 | 2082 | 0.040 |
Why?
| | Vitamin B 12 | 1 | 2019 | 115 | 0.040 |
Why?
| | Choline | 1 | 2019 | 108 | 0.040 |
Why?
| | Absorptiometry, Photon | 1 | 2019 | 221 | 0.040 |
Why?
| | DNA | 2 | 1996 | 1356 | 0.040 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2019 | 193 | 0.040 |
Why?
| | Polyubiquitin | 1 | 1996 | 7 | 0.040 |
Why?
| | Gene Expression | 1 | 2001 | 1436 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1996 | 104 | 0.030 |
Why?
| | Codon | 1 | 1996 | 86 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1996 | 327 | 0.030 |
Why?
| | Chromosome Painting | 1 | 2014 | 1 | 0.030 |
Why?
| | Breeding | 1 | 2014 | 55 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1994 | 150 | 0.030 |
Why?
| | Housing, Animal | 1 | 2014 | 45 | 0.030 |
Why?
| | Humans | 4 | 2015 | 115739 | 0.030 |
Why?
| | Microsatellite Repeats | 1 | 2014 | 137 | 0.030 |
Why?
| | Anxiety | 1 | 2019 | 854 | 0.030 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2014 | 310 | 0.030 |
Why?
| | Gonadotropins, Equine | 1 | 2011 | 3 | 0.020 |
Why?
| | Cleavage Stage, Ovum | 1 | 2011 | 7 | 0.020 |
Why?
| | Estrous Cycle | 1 | 2011 | 15 | 0.020 |
Why?
| | Embryo Culture Techniques | 1 | 2011 | 12 | 0.020 |
Why?
| | Embryo Transfer | 1 | 2011 | 29 | 0.020 |
Why?
| | Chorionic Gonadotropin | 1 | 2011 | 78 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2011 | 69 | 0.020 |
Why?
| | Introns | 1 | 2011 | 226 | 0.020 |
Why?
| | Cattle | 1 | 2011 | 935 | 0.020 |
Why?
| | AlkB Homolog 1, Histone H2a Dioxygenase | 1 | 2008 | 1 | 0.020 |
Why?
| | Synteny | 1 | 2008 | 17 | 0.020 |
Why?
| | DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2008 | 2 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2008 | 38 | 0.020 |
Why?
| | Euchromatin | 1 | 2008 | 3 | 0.020 |
Why?
| | Two-Hybrid System Techniques | 1 | 2008 | 52 | 0.020 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2008 | 21 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2011 | 369 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2008 | 154 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2008 | 258 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2008 | 298 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2008 | 297 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2008 | 398 | 0.020 |
Why?
| | Molecular Chaperones | 1 | 2008 | 157 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2008 | 465 | 0.020 |
Why?
| | Models, Genetic | 1 | 2008 | 570 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2008 | 2604 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1537 | 0.010 |
Why?
|
|
Vrana's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|